(5-Bromo-6-methylpyridin-2-yl)methanol, 98+%, 10g

Acétylacétone, min.98%, pour la synthèse, 2,5 L, emballage en verre

[(3-tert-butyl-1H-pyrazol-5-yl)methyl]amine dihydrochloride hydrate, 95.0%, 1g

N-Ethylcyclopropanamine hydrochloride, 96%, 10g

tert-Butyl ethyl(2-hydroxyethyl)carbamate, 95.0%, 25g

Methyl 3-Oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carboxylate, 97.0%, 10g

BIS[2-((OXO)DIPHENYLPHOSPHINO)PHENYL]ETHER, 97%, 5g

1,3-Dimethyl-2-(2-thienyl)imidazolidine5g

Hydroxyde de potassium, min 85%, Ph.Eur., en pastilles, 25 kg, emballage plastique.

(S)-Methyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate, 96%, 10g

Ethyl 1-(4-aminopyridin-2-yl)-1H-pyrazole-4-carboxylate, 95.0%, 100mg

(2-Chloro-4-iodophenyl)hydrazine hydrochloride, 95.0%, 250mg

N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine, 100mg